Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anterix (ATEX) EBITDA (2016 - 2025)

Anterix's EBITDA history spans 13 years, with the latest figure at -$9.1 million for Q4 2025.

  • For Q4 2025, EBITDA fell 228.85% year-over-year to -$9.1 million; the TTM value through Dec 2025 reached $83.5 million, up 364.04%, while the annual FY2025 figure was -$11.2 million, 20.3% down from the prior year.
  • EBITDA reached -$9.1 million in Q4 2025 per ATEX's latest filing, down from $60.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $60.7 million in Q3 2025 to a low of -$15.0 million in Q2 2024.
  • Average EBITDA over 5 years is -$613150.0, with a median of -$8.7 million recorded in 2022.
  • The largest YoY upside for EBITDA was 625.7% in 2024 against a maximum downside of 681.23% in 2024.
  • A 5-year view of EBITDA shows it stood at -$12.4 million in 2021, then skyrocketed by 32.09% to -$8.4 million in 2022, then soared by 111.53% to $969000.0 in 2023, then skyrocketed by 625.7% to $7.0 million in 2024, then tumbled by 228.85% to -$9.1 million in 2025.
  • Per Business Quant, the three most recent readings for ATEX's EBITDA are -$9.1 million (Q4 2025), $60.7 million (Q3 2025), and $22.5 million (Q2 2025).